Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Comparable to guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1993
Report date:
1993

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
EU Method B.1 (Acute Toxicity (Oral))
Version / remarks:
Cited as Directive 84/449/EEC, B.1 (modified according to the acute toxic class method)
GLP compliance:
yes
Test type:
acute toxic class method

Test material

Constituent 1
Chemical structure
Reference substance name:
[(2E)-3-(5,5-dimethyl-1,3-dioxan-2-yl)-2-butenyl]triphenylphosphonium chloride
EC Number:
613-004-8
Cas Number:
62285-89-6
Molecular formula:
C28 H32 O2 P . Cl
IUPAC Name:
[(2E)-3-(5,5-dimethyl-1,3-dioxan-2-yl)-2-butenyl]triphenylphosphonium chloride
Details on test material:
- Name of test material (as cited in study report): C5-NPG-ACETAL
- Substance Number: 92/128
- Physical state: white powder
- Analytical purity: 99 %
- Lot/batch No.: 92/33 - 1 (TECHNIKUM B 15 S)
- Stability under test conditions: The stability of the test substance in aqua bidest. for at least 4 hours was confirmed by analysis.
- Storage condition of test material: refrigerator; exclusion of moisture

Test animals

Species:
rat
Strain:
Wistar
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Dr. K. Thomae GmbH, Biberach, Germany
- Age at study initiation: young adult animals
- Weight at study initiation: 150g - 300g 20% of the mean weight
- Fasting period before study: the animals were given no feed at least 16 hours before administration, but water was available ad libitum.
- Housing: single housing
- Diet (e.g. ad libitum): Diet: Kliba-Labordiaet 343, Klingentalmuehle AG, Kaiseraugst, Switzerland, ad libitum
- Water (e.g. ad libitum): tap water, ad libitum
- Acclimation period: at least 1 week

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 - 24
- Humidity (%): 30 - 70
- Photoperiod (hrs dark / hrs light): 12 h/12 h

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
water
Details on oral exposure:
VEHICLE
- Concentration in vehicle: 2 g / 100 mL and 20 g / 100 mL
- Amount of vehicle (if gavage): 10 ml/kg
- Justification for choice of vehicle: aqueous formulation corresponds to the physiological medium

MAXIMUM DOSE VOLUME APPLIED: 10 ml/kg

Doses:
200 and 2000 mg / kg body weight
No. of animals per sex per dose:
3
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing:
- Body weight determination: individual body weights shortly before application (day 0), weekly thereafter and at the end of the study (before fating period)
- Signs and symptoms serveral times on the day of administration, at least once each workday for the individual animals
- General observations and Mortality: A check was made twice each workday and once on saturdays, sundays and on public holidays for
general observations and for any dead or moribund animals.
- Necropsy of survivors performed: yes, at the last day of the observation period. Withdrawal of food at least 16 hours before killing with C02; then necropsy with grosspathology examination. Necropsy of all animals that died before as early as possible.

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 200 - < 2 000 mg/kg bw
Remarks on result:
other: At the concentration of 2000 mg /kg body weight all animals died.
Mortality:
200 mg / kg body weight: Males: No animal died; Females: One animal of 3 died within 1 hour.
2000 mg / kg body weight: Males: all animals died immediately after gavage.
Clinical signs:
Females: 200 mg / kg body weight: poor general state (2 animals, hour 4 to day 1); dyspnoea (2 animals; hour 4 to day 1); apathy (2 animals, hour 4 to day 1); staggering (1 animal, hour 4 to day 1); piloerection (2 animals, hour 1 to day 1); diarrhea (2 animals, hour 1 to hour 4).

Males:
- 200 mg / kg body weight: poor general state (3 animals, hour 0 to day 9); dyspnoea (3 animals; hour 0 to day 9); apathy (3 animals, hour 0 to day 9); staggering (3 animals, day 1 to 9); ataxia (3 animals, day 5 to 9); tremor (1 animal, day 1); piloerection (3 animals, hour 0 to day 9); smeared fur (3 animals, day 9); exsiccosis (3 animals, day 5 to 8); discoloured urine (1 animals, day 1 to 2).
- 2000 mg / kg body weight: poor general state (3 animals, hour 0); dyspnoea (2 animals; hour 0); gasping (3 animals, hour 0); apathy (3 animals, hour 0); abdominal position (2 animals, hour 0); lateral position (1 animal, hour 0); cyanosis (3 animals, hour 0); salivation (1 animal, hour 0).

Body weight:
Males: No effects.
Gross pathology:
Animals that died:
- general congestion: 200 mg / kg body weight: one female; 2000 mg / kg body weight: 3 males;
- liver: marked black-red discolouration: 2000 mg / kg body weight: 3 males;

Sacrificed animals:
- no pathological findings in 3 males and 2 females of the low dose group.
Other findings:
No other findings.

Applicant's summary and conclusion